| Overview |
| bsm-52128r-apc-cy7-100ul |
| Peroxiredoxin 2 (19A1) Monoclonal Antibody, APC-Cy7 Conjugated |
| WB, Flow-Cyt |
| Human, Mouse, Rat |
| Specifications |
| APC-Cy7 |
| Rabbit |
| Recombinant human Peroxiredoxin 2 protein, full length. |
| Monoclonal |
| 19A1 |
| IgG |
| Lot Dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 7001 |
| P32119 |
| PRP; TSA; PRX2; PTX1; TPX1; NKEFB; PRXII; TDPX1; NKEF-B; HEL-S-2a; Peroxiredoxin-2; Natural killer cell-enhancing factor B; Thiol-specific antioxidant protein; Thioredoxin peroxidase 1; Thioredoxin-dependent peroxide reductase 1; PRDX2 |
| Involved in redox regulation of the cell. Reduces peroxides with reducing equivalents provided through the thioredoxin system. It is not able to receive electrons from glutaredoxin. May play an important role in eliminating peroxides generated during metabolism. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2). |
| Application Dilution |
| WB |
1:1000-2000 |
| Flow-Cyt |
1:50-100 |